ORIC · NASDAQ
Oric Pharmaceuticals (ORIC) Stock Price & Fundamentals
Oric Pharmaceuticals (ORIC) closed at $562.03 on Oct 9, 2026, down 1.08% from the previous close of $568.18.
Share price, past year
1Y +18.15%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $562.03 |
| Sep 30, 2026 | $580.05 |
| Aug 31, 2026 | $655.44 |
| Jul 31, 2026 | $644.52 |
| Jun 30, 2026 | $590.75 |
| May 29, 2026 | $628.08 |
| Apr 30, 2026 | $591.26 |
| Mar 31, 2026 | $585.38 |
| Feb 27, 2026 | $569.40 |
| Jan 30, 2026 | $589.00 |
| Dec 31, 2025 | $553.49 |
| Nov 28, 2025 | $513.24 |
| Oct 31, 2025 | $517.62 |
Key statistics
- Market cap
- $58.25B
- EPS (TTM)
- −$1.30
- Net income (TTM)
- −$140.35M
- Shares outstanding
- 103.6M
- 52-week range
- $475.71 – $677.82
Oric Pharmaceuticals's market cap is $58.25B, based on a share price of $562.03 and 103.6M shares outstanding as of Jun 30, 2026.
Financials
Oric Pharmaceuticals's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Oric Pharmaceuticals reported a net loss of $129.47M in fiscal 2025.
Company profile
- Name
- Oric Pharmaceuticals, Inc.
- Ticker
- ORIC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 240 E. Grand Ave., 2nd Floor, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001796280
Recent SEC filings
- Aug 3, 2026
- Aug 3, 2026
- Jul 30, 2026
- Jun 22, 2026
- May 4, 2026
- May 4, 2026
- Mar 31, 2026
- Feb 23, 2026
Frequently asked questions
What is Oric Pharmaceuticals's stock price?
Oric Pharmaceuticals (ORIC) closed at $562.03 on Oct 9, 2026, down 1.08% from the previous close of $568.18.
What is Oric Pharmaceuticals's market cap?
Oric Pharmaceuticals's market cap is $58.25B, based on a share price of $562.03 and 103.6M shares outstanding as of Jun 30, 2026.
Does Oric Pharmaceuticals pay a dividend?
Oric Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Oric Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures